EDGAR Filing Documents for 0001209191-15-002621

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001209191-15-002621

Filing Date

2015-01-06

Accepted

2015-01-06 20:13:51

Documents

Period of Report

2015-01-04

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 SUBMISSION	doc4.html	4
1	FORM 4 SUBMISSION	doc4.xml	4	8272
	Complete submission text file	0001209191-15-002621.txt		9549

Mailing Address

Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE NEW YORK NY 10022

Business Address

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 15511825